What seems specific for gliomas is activation of the mTOR pathway (mammalian target of rapamycin) by EGF via protein kinase C alpha, apparently through an independent circuit from the classical Akt-mTOR activation [119]. The gene discussed is AKT1; the disease is central nervous system cancer.